stockCELYAD ONCOLOGY Stock Went Down By Over 29% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockBIOSENIC Stock Bearish Momentum With A 30% Slide In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockCGG Stock Bearish Momentum With A 21% Drop In The Last 10 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockARAMIS GROUP Stock Bearish By 31% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockVERIMATRIX Stock Over 22% Down In The Last 10 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockINVENTIVA Stock Drops By 32% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockCROSSWOOD Stock Went Down By Over 14% So Far On TuesdayViaNews Editorial Team (Europe)•Mar 21, 2023
stockBASILIX CERT Stock Falls 9% So Far On Tuesday, Underperforms MarketViaNews Editorial Team (Europe)•Mar 21, 2023
stockTHUNDERBIRD Stock Is 21% Down In The Last 5 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockTECHNICOLOR CS Stock Drops By 34% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockKONGSBERG AUTOMOT Stock Bearish By 28% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockASETEK Stock Over 9% Down At Session Start On TuesdayViaNews Editorial Team (Europe)•Mar 21, 2023
stockVITURA Stock Bearish Momentum With A 22% Fall In The Last 10 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockTERACT BS Stock Went Down By Over 25% In The Last 5 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockABL Diagnostics Stock Drops By 26% In The Last 10 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockBIOSENIC Stock Slides By 30% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockTERACT BS Stock Bearish Momentum With A 25% Drop In The Last 5 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockTECHNICOLOR CS Stock Slides By 34% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockLAVIDE HOLDING Stock Is 32% Down In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023